Comparison of Oxygen Reserve Index and Regional Cerebral Oxygen Saturation Indetermining Hypoxia in Obese Patients
Launched by DR. LUTFI KIRDAR KARTAL TRAINING AND RESEARCH HOSPITAL · May 4, 2024
Trial Information
Current as of June 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two methods, called the Oxygen Reserve Index (ORI) and regional cerebral oxygen saturation (rcSO2), to see which one is better at spotting low oxygen levels early in obese patients. This is important because some obese individuals are more likely to experience oxygen deficiency, especially during surgery. The study aims to understand not only how effective these methods are but also if changes in ORI and rcSO2 happen at the same time in these patients.
To participate in this trial, candidates need to be aged between 18 and 75 years and have a body mass index (BMI) between 30 and 40, meaning they are considered obese. They should be scheduled for elective surgery that requires intubation (where a tube is placed in the airway to help with breathing). However, individuals with serious heart or lung problems, those outside the specified age or BMI range, or those with a higher health risk classification (ASA >3) cannot participate. If eligible, participants can expect to undergo monitoring during their surgery to help researchers gather information about which method works best for detecting low oxygen levels.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I-III patients
- • The ages of 18-75
- • Obese BMI (40\>BMI\>30 kgm\^2)
- • Undergoing intubated elective surgery
- Exclusion Criteria:
- • Patients with significant cardiopulmonary comorbidities
- • BMI\>40 kgm\^2 and BMI\<30 kg m\^2
- • ASA\>3
- • Patients under 18 years and over 75 years of age
About Dr. Lutfi Kirdar Kartal Training And Research Hospital
Dr. Lutfi Kirdar Kartal Training and Research Hospital is a prominent healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical research. Located in Kartal, Istanbul, the hospital combines state-of-the-art facilities with a commitment to education and training, fostering an environment where medical professionals can collaborate on groundbreaking studies. With a focus on various therapeutic areas, the hospital actively sponsors clinical trials aimed at enhancing treatment methodologies and contributing to the global medical community. Through rigorous protocols and ethical practices, Dr. Lutfi Kirdar Kartal Training and Research Hospital plays a vital role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Gülten A Arslan, Assos Prof
Principal Investigator
Dr Lütfi Kırdar City Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported